Choong Ang Vaccine Laboratory Co., Ltd. (KOSDAQ:072020)
9,950.00
+50.00 (0.51%)
Feb 18, 2025, 9:00 AM KST
KOSDAQ:072020 Revenue
Choong Ang Vaccine Laboratory had revenue of 10.23B KRW in the quarter ending March 31, 2023, a decrease of -1.05%. This brings the company's revenue in the last twelve months to 39.19B, down -4.18% year-over-year. In the year 2022, Choong Ang Vaccine Laboratory had annual revenue of 39.30B, down -3.95%.
Revenue (ttm)
39.19B
Revenue Growth
-4.18%
P/S Ratio
2.48
Revenue / Employee
234.67M
Employees
167
Market Cap
95.68B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 39.30B | -1.61B | -3.95% |
Dec 31, 2021 | 40.91B | 4.60B | 12.66% |
Dec 31, 2020 | 36.32B | 17.05B | 88.53% |
Dec 31, 2012 | 19.26B | 3.67B | 23.57% |
Dec 31, 2011 | 15.59B | -507.67M | -3.15% |
Dec 31, 2010 | Pro | Pro | Pro |
Dec 31, 2009 | Pro | Pro | Pro |
Dec 31, 2008 | Pro | Pro | Pro |
Dec 31, 2007 | Pro | Pro | Pro |
Dec 31, 2006 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 300.87T |
SK hynix | 57.73T |
LG Energy Solution | 25.62T |
Samsung Biologics | 4,364.39B |
Hyundai Motor Company | 170.28T |
Celltrion | 2,876.25B |
Kia Corporation | 104.63T |
NAVER | 10.39T |